We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$663M
AUM Growth
-$835M
Cap. Flow
-$859M
Cap. Flow %
-129.52%
Top 10 Hldgs %
36.6%
Holding
684
New
251
Increased
107
Reduced
109
Closed
206

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$123M
2
BABA icon
Alibaba
BABA
+$16.4M
3
AMD icon
Advanced Micro Devices
AMD
+$12.3M
4
MELI icon
Mercado Libre
MELI
+$12.3M
5
CDNS icon
Cadence Design Systems
CDNS
+$10.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$541M
2
IBB icon
iShares Biotechnology ETF
IBB
+$152M
3
PFE icon
Pfizer
PFE
+$147M
4
LLY icon
Eli Lilly
LLY
+$77.2M
5
GILD icon
Gilead Sciences
GILD
+$66M

Sector Composition

Rank Sector Weight
1 Materials 20.16%
2 Technology 17.81%
3 Consumer Discretionary 13.64%
4 Healthcare 9.49%
5 Financials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTAS icon
201
Cintas
CTAS
$80.9B
$722K 0.11%
+6,244
New +$688K
OTIS icon
202
Otis Worldwide
OTIS
$27.7B
$717K 0.11%
+8,501
New +$703K
CVS icon
203
CVS Health
CVS
$122B
$715K 0.11%
9,622
+1,607
+20% +$135K
ZD icon
204
Ziff Davis
ZD
$1.99B
$711K 0.11%
9,111
– –
OSUR icon
205
OraSure Technologies
OSUR
$274M
$701K 0.11%
115,949
-37,930
-25% -$214K
INVX
206
Innovex International
INVX
$2.02B
$692K 0.1%
24,120
+9,726
+68% +$288K
PSEC icon
207
Prospect Capital
PSEC
$1.14B
$692K 0.1%
99,366
+14,657
+17% +$106K
BMY icon
208
Bristol-Myers Squibb
BMY
$133B
$691K 0.1%
9,964
-15,940
-62% -$1.12M
YEXT icon
209
Yext
YEXT
$575M
$684K 0.1%
71,197
+59,514
+509% +$458K
AMED
210
DELISTED
Amedisys
AMED
$679K 0.1%
9,237
-5,063
-35% -$438K
ADMA icon
211
ADMA Biologics
ADMA
$2.17B
$678K 0.1%
204,919
-30,256
-13% -$105K
ALRM icon
212
Alarm.com
ALRM
$2.81B
$674K 0.1%
13,413
+1,279
+11% +$65.8K
KRC icon
213
Kilroy Realty
KRC
$4.31B
$674K 0.1%
20,811
+13,233
+175% +$482K
TMO icon
214
Thermo Fisher Scientific
TMO
$221B
$674K 0.1%
+1,169
New +$659K
IDXX icon
215
Idexx Laboratories
IDXX
$47.3B
$673K 0.1%
+1,346
New +$644K
CABO icon
216
Cable One
CABO
$202M
$670K 0.1%
+954
New +$694K
XRX icon
217
Xerox
XRX
$424M
$651K 0.1%
42,279
-3,006
-7% -$48.6K
API
218
Agora
API
$379M
$649K 0.1%
179,346
-105,999
-37% -$406K
CNO icon
219
CNO Financial Group
CNO
$5.12B
$647K 0.1%
+29,140
New +$696K
INO icon
220
Inovio Pharmaceuticals
INO
$73.4M
$643K 0.1%
65,390
+16,793
+35% +$286K
WOOF icon
221
Petco
WOOF
$785M
$625K 0.09%
69,394
+42,015
+153% +$435K
YELP icon
222
Yelp
YELP
$1.34B
$624K 0.09%
20,316
-12,216
-38% -$367K
ARW icon
223
Arrow Electronics
ARW
$10.5B
$623K 0.09%
4,993
-3,699
-43% -$439K
ONTF
224
DELISTED
ON24
ONTF
$616K 0.09%
70,335
-20,845
-23% -$184K
VMEO
225
DELISTED
Vimeo
VMEO
$615K 0.09%
+160,454
New +$629K
7 8
9
10 11

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q1 2023 Portfolio in Review

As of Q1 2023, Caxton Associates (New York) held 684 positions worth $663M, down 56% from $1.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Caxton Associates (New York) withdrew a net $859M in Q1 2023, closing 206 positions and reducing 109 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 0.33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Caxton Associates (New York) opened a new position in Advanced Micro Devices worth $14.8M.

  • Caxton Associates (New York)'s largest Q1 2023 buy was Advanced Micro Devices: 151,421 shares worth $14.8M.
  • Caxton Associates (New York) added most to Freeport-McMoran in Q1 2023, an estimated $123M increase.
  • Caxton Associates (New York)'s biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $541M.
  • Caxton Associates (New York) fully exited iShares Biotechnology ETF in Q1 2023, selling an estimated $152M.
  • Caxton Associates (New York)'s ten largest holdings make up 37% of its $663M portfolio in Q1 2023.
  • Caxton Associates (New York) opened 251 new positions and closed 206 in Q1 2023.
  • Caxton Associates (New York)'s portfolio value fell 56% quarter-over-quarter to $663M.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.